TRAVERE THERAPEUTICS INC's ticker is and the CUSIP is 89422GAA5. A total of 26 filers reported holding TRAVERE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $26,722 | +13.9% | 41,167 | +41.1% | 2.14% | +1.0% |
| Q2 2023 | $23,461 | +31.4% | 29,167 | +60.5% | 2.12% | +41.5% |
| Q1 2023 | $17,858 | -15.8% | 18,167 | -21.6% | 1.50% | -3.4% |
| Q4 2022 | $21,198 | -99.6% | 23,167 | +363.3% | 1.55% | +353.5% |
| Q3 2022 | $5,088,000 | +24.3% | 5,000 | +22.0% | 0.34% | +16.7% |
| Q2 2022 | $4,092,000 | -33.3% | 4,100 | -28.7% | 0.29% | -26.6% |
| Q1 2022 | $6,138,000 | – | 5,750 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 45,000,000 | $474,089,000 | 9.50% |
| ABSOLUTE INVESTMENT ADVISERS, LLC | 4,000,000 | $4,280,000 | 0.96% |
| DeepCurrents Investment Group LLC | 22,150,000 | $23,650,000 | 0.74% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 19,000,000 | $19,967,000 | 0.46% |
| Context Capital Management, LLC | 5,750 | $6,138,000 | 0.40% |
| WOLVERINE ASSET MANAGEMENT LLC | 34,000,000 | $36,271,000 | 0.35% |
| Polar Asset Management Partners Inc. | 15,000,000 | $15,993,000 | 0.17% |
| LINDEN ADVISORS LP | 20,000,000 | $21,281,000 | 0.13% |
| Wellesley Asset Management | 1,599 | $1,599,000 | 0.11% |
| Verition Fund Management LLC | 6,213,000 | $6,614,000 | 0.08% |